Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent.

Tewari MK, Sinnathamby G, Rajagopal D, Eisenlohr LC.

Nat Immunol. 2005 Mar;6(3):287-94. Epub 2005 Feb 13. Erratum in: Nat Immunol. 2005 Apr;6(4):420.

PMID:
15711549
3.
4.

Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.

Becker HJ, Kondo E, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon MS.

Eur J Haematol. 2016 Aug;97(2):166-74. doi: 10.1111/ejh.12699. Epub 2015 Dec 10.

PMID:
26561366
6.
7.

A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.

Herberts CA, Stittelaar KJ, van der Heeft E, van Gaans-Van den Brink J, Poelen MC, Roholl PJ, van Alphen LJ, Melief CJ, de Jong AP, van Els CA.

J Gen Virol. 2001 Sep;82(Pt 9):2131-42.

PMID:
11514722
8.

Dominant contribution of the proteasome and metalloproteinases to TAP-independent MHC-I peptide repertoire.

Oliveira CC, Sluijter M, Querido B, Ossendorp F, van der Burg SH, van Hall T.

Mol Immunol. 2014 Nov;62(1):129-36. doi: 10.1016/j.molimm.2014.06.006. Epub 2014 Jun 28.

PMID:
24983205
9.

Proteasomes, TAP, and endoplasmic reticulum-associated aminopeptidase associated with antigen processing control CD4+ Th cell responses by regulating indirect presentation of MHC class II-restricted cytoplasmic antigens.

Dragovic SM, Hill T, Christianson GJ, Kim S, Elliott T, Scott D, Roopenian DC, Van Kaer L, Joyce S.

J Immunol. 2011 Jun 15;186(12):6683-92. doi: 10.4049/jimmunol.1100525. Epub 2011 May 13.

10.

Mouse endothelial cells cross-present lymphocyte-derived antigen on class I MHC via a TAP1- and proteasome-dependent pathway.

Bagai R, Valujskikh A, Canaday DH, Bailey E, Lalli PN, Harding CV, Heeger PS.

J Immunol. 2005 Jun 15;174(12):7711-5.

11.

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, Amigorena S.

J Exp Med. 1999 Jan 18;189(2):371-80.

12.

Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.

Mukherjee P, Dani A, Bhatia S, Singh N, Rudensky AY, George A, Bal V, Mayor S, Rath S.

J Immunol. 2001 Sep 1;167(5):2632-41.

13.

Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.

Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert P, Schild H, Rammensee HG, Stevanović S.

Eur J Immunol. 2008 Jun;38(6):1503-10. doi: 10.1002/eji.200838136.

15.

Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.

Luckey CJ, King GM, Marto JA, Venketeswaran S, Maier BF, Crotzer VL, Colella TA, Shabanowitz J, Hunt DF, Engelhard VH.

J Immunol. 1998 Jul 1;161(1):112-21.

17.

Biosynthesis of major histocompatibility complex molecules and generation of T cells in Ii TAP1 double-mutant mice.

Tourne S, van Santen HM, van Roon M, Berns A, Benoist C, Mathis D, Ploegh H.

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1464-9.

19.
20.

The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.

Dani A, Chaudhry A, Mukherjee P, Rajagopal D, Bhatia S, George A, Bal V, Rath S, Mayor S.

J Cell Sci. 2004 Aug 15;117(Pt 18):4219-30.

Supplemental Content

Support Center